Literature DB >> 26069247

Network-Based Approaches to Understand the Roles of miR-200 and Other microRNAs in Cancer.

Cameron P Bracken1, Yeesim Khew-Goodall2, Gregory J Goodall3.   

Abstract

microRNAs (miRNA) are well suited to the task of regulating gene expression networks, because any given miRNA has the capacity to target dozens, if not hundreds, of genes. The simultaneous targeting of multiple genes within a pathway may enable miRNAs to more strongly regulate the pathway, or to achieve more subtle control through the targeting of distinct subnetworks of genes. Therefore, as our capacity to discover miRNA targets en masse increases, so must our consideration of the complex networks in which these genes participate. We highlight recent studies in which the comprehensive identification of targets has been used to elucidate miRNA-regulated gene networks in cancer, focusing especially upon miRNAs such as members of the miR-200 family that regulate epithelial-mesenchymal transition (EMT), a reversible phenotypic switch whereby epithelial cells take on the more invasive properties of their mesenchymal counterparts. These studies have expanded our understanding of the roles of miRNAs in EMT, which were already known to form important regulatory loops with key transcription factors to regulate the epithelial or mesenchymal properties of cells. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26069247     DOI: 10.1158/0008-5472.CAN-15-0287

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  28 in total

1.  miR-8 modulates cytoskeletal regulators to influence cell survival and epithelial organization in Drosophila wings.

Authors:  Kelsey Bolin; Nicholas Rachmaninoff; Kea Moncada; Katharine Pula; Jennifer Kennell; Laura Buttitta
Journal:  Dev Biol       Date:  2016-02-21       Impact factor: 3.582

Review 2.  Therapeutic potential of microRNAs for the treatment of renal fibrosis and CKD.

Authors:  Wenshan Lv; Fan Fan; Yangang Wang; Ezekiel Gonzalez-Fernandez; Chen Wang; Lili Yang; George W Booz; Richard J Roman
Journal:  Physiol Genomics       Date:  2017-11-10       Impact factor: 3.107

3.  MicroRNA-200b inhibits pituitary tumor cell proliferation and invasion by targeting PKCα.

Authors:  Yuanchuan Wang; Xiaohong Yin; Long Zhao; Shun Li; Jie Duan; Renzhao Kuang; Junwei Duan
Journal:  Exp Ther Med       Date:  2017-06-27       Impact factor: 2.447

Review 4.  Review article epithelial to mesenchymal transition‑associated microRNAs in breast cancer.

Authors:  Hossein Javdani; Homa Mollaei; Farzaneh Karimi; Shiva Mahmoudi; Ali Farahi; Mohamad Javad Mirzaei-Parsa; Arman Shahabi
Journal:  Mol Biol Rep       Date:  2022-06-18       Impact factor: 2.742

Review 5.  The Regulatory Role of MicroRNAs on Phagocytes: A Potential Therapeutic Target for Chronic Diseases.

Authors:  Yongbo Wang; Xingyu Liu; Panpan Xia; Zhangwang Li; Xinxi FuChen; Yunfeng Shen; Peng Yu; Jing Zhang
Journal:  Front Immunol       Date:  2022-05-11       Impact factor: 8.786

6.  PEP06 polypeptide 30 exerts antitumour effect in colorectal carcinoma via inhibiting epithelial-mesenchymal transition.

Authors:  Siming Yu; Linna Li; Wei Tian; Dan Nie; Wei Mu; Fang Qiu; Yu Liu; Xinghan Liu; Xiaofeng Wang; Zhimin Du; Wen-Feng Chu; Baofeng Yang
Journal:  Br J Pharmacol       Date:  2018-06-15       Impact factor: 8.739

7.  Detection of Drug-Induced Acute Kidney Injury in Humans Using Urinary KIM-1, miR-21, -200c, and -423.

Authors:  Mira Pavkovic; Cassianne Robinson-Cohen; Alicia S Chua; Oana Nicoara; Mariana Cárdenas-González; Vanesa Bijol; Krithika Ramachandran; Lucy Hampson; Munir Pirmohamed; Daniel J Antoine; Gyorgy Frendl; Jonathan Himmelfarb; Sushrut S Waikar; Vishal S Vaidya
Journal:  Toxicol Sci       Date:  2016-04-27       Impact factor: 4.849

8.  Development of a miRNA-based classifier for detection of colorectal cancer molecular subtypes.

Authors:  Ronja S Adam; Dennis Poel; Leandro Ferreira Moreno; Joey M A Spronck; Tim R de Back; Arezo Torang; Patricia M Gomez Barila; Sanne Ten Hoorn; Florian Markowetz; Xin Wang; Henk M W Verheul; Tineke E Buffart; Louis Vermeulen
Journal:  Mol Oncol       Date:  2022-04-29       Impact factor: 7.449

9.  Targeting Long Non-Coding RNAs in Hepatocellular Carcinoma: Progress and Prospects.

Authors:  Xinrong Lin; Xiaosong Xiang; Bing Feng; Hao Zhou; Ting Wang; Xiaoyuan Chu; Rui Wang
Journal:  Front Oncol       Date:  2021-06-25       Impact factor: 6.244

10.  miR-655 suppresses epithelial-to-mesenchymal transition by targeting Prrx1 in triple-negative breast cancer.

Authors:  Zhi-Dong Lv; Bin Kong; Xiang-Ping Liu; Li-Ying Jin; Qian Dong; Fu-Nian Li; Hai-Bo Wang
Journal:  J Cell Mol Med       Date:  2016-01-28       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.